ichorlabs.org valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Crawl-Delay:
Meta Tags
Title IchorLabs
Description Reinventing liquid biopsy for Home Technology About us Media ☰ Home Technology About us Media Reinventing liquid biopsy for all Our vision is to provide revolutionary technology for th
Keywords N/A
Server Information
WebSite ichorlabs faviconichorlabs.org
Host IP 185.69.148.101
Location Slovenia
Related Websites
Site Rank
More to Explore
ichorlabs.org Valuation
US$1,470
Last updated: 2023-05-02 01:36:16

ichorlabs.org has Semrush global rank of 0. ichorlabs.org has an estimated worth of US$ 1,470, based on its estimated Ads revenue. ichorlabs.org receives approximately 169 unique visitors each day. Its web server is located in Slovenia, with IP address 185.69.148.101. According to SiteAdvisor, ichorlabs.org is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,470
Daily Ads Revenue US$1
Monthly Ads Revenue US$40
Yearly Ads Revenue US$488
Daily Unique Visitors 11
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
ichorlabs.org. A 7199 IP: 185.69.148.101
ichorlabs.org. NS 86400 NS Record: dns2.hitrost.net.
ichorlabs.org. NS 86400 NS Record: dns1.hitrost.net.
ichorlabs.org. MX 7200 MX Record: 10 mail.ichorlabs.org.
ichorlabs.org. TXT 7200 TXT Record: v=spf1 a mx ip4:91.185.211.0/24 ip4:185.69.148.0/22 ~all
HtmlToTextCheckTime:2023-05-02 01:36:16
Home Technology About us Media ☰ Home Technology About us Media Reinventing liquid biopsy for all Our vision is to provide revolutionary technology for the rapid improvement of non-invasive early cancer detection tests. Welcome to IchorLabs IchorLabs is a biotechnology company with the primary focus to improve current non-invasive diagnostic tests in the areas of oncology, prenatal diagnostics and infectious diseases. We offer an innovative technology which has the potential to revolutionize liquid biopsy diagnostic tests. Our patent-pending technology features high-yield separation of genetic biomarkers from body fluids for supporting liquid biopsy testing with high detection sensitivity. Liquid biopsy Liquid biopsy refers to the analysis of any biomarker (usually cell-free nucleic acids) obtained from body fluids, such as blood, urine or saliva with a non-invasive or minimally invasive technique. Accumulate Our patent-pending technology allows accumulation of cell-free nucleic acids
HTTP Headers
HTTP/1.1 200 OK
Server: nginx
Date: Sun, 24 Oct 2021 13:40:31 GMT
Content-Type: text/html
Content-Length: 9352
Connection: keep-alive
Vary: Accept-Encoding
X-Accel-Version: 0.01
Last-Modified: Tue, 21 Nov 2017 12:39:23 GMT
ETag: "2488-55e7d7e1854c0"
Accept-Ranges: bytes
Vary: Accept-Encoding,User-Agent
ichorlabs.org Whois Information
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS